Literature DB >> 20179175

Feasibility, safety, and outcome of a challenging transseptal puncture facilitated by radiofrequency energy delivery: a prospective single-centre study.

Lucio Capulzini1, Gaetano Paparella, Antonio Sorgente, Carlo de Asmundis, Gian Battista Chierchia, Andrea Sarkozy, Andreas Muller-Burri, Yoshinao Yazaki, Markus Roos, Pedro Brugada.   

Abstract

AIMS: Although it has been shown that a transseptal (TS) puncture in the electrophysiology laboratory is associated with a high success and a low complication rate, this procedure remains challenging particularly in difficult septum anatomies (aneurismal septum and thick septum) and during repeat TS catheterization. Radiofrequency (RF) electrocautery current delivery through the TS needle has been shown to facilitate the TS puncture. The aim of this study was to verify prospectively the feasibility, safety, and outcome of RF energy delivery associated with the standard TS technique in patients undergoing a challenging TS puncture. METHODS AND
RESULTS: Over a 14-month period, 162 consecutive patients underwent left atrial (LA) arrhythmia ablation in our centre. Among them, we enrolled 18 patients who failed LA access after two TS puncture attempts. In these patients, an RF delivery through TS (RF-TS) needle approach was used to reach the LA. All 18 patients had a successful RF-TS at the first attempt. A transoesophageal echocardiography (TEE) guidance and fluoroscopy views were used in all patients. No acute complications were reported. There have been no clinical sequelae after 10 +/- 4 months of follow-up following the RF-TS approach. Challenging TS punctures were more frequent in repeat LA catheterization when compared with the first LA catheterization, respectively, in 35% (13 of 37) and 4% (5 of 125) of the patients.
CONCLUSION: Radiofrequency electrocautery delivery associated with the standard TS approach is a safe and reproducible technique to reach the left atrium, using the TEE guidance. This technique is helpful during repeat TS catheterization and in the presence of anatomical atrial septum abnormalities.

Entities:  

Mesh:

Year:  2010        PMID: 20179175     DOI: 10.1093/europace/euq019

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  5 in total

Review 1.  Transseptal Puncture: Devices, Techniques, and Considerations for Specific Interventions.

Authors:  Sharan Prakash Sharma; Rahul Nalamasu; Rakesh Gopinathannair; Chandrasekhar Vasamreddy; Dhanunjaya Lakkireddy
Journal:  Curr Cardiol Rep       Date:  2019-05-07       Impact factor: 2.931

2.  Prospective comparison between conventional transseptal puncture and transseptal needle puncture with radiofrequency energy.

Authors:  Stéphane Fromentin; Jean-François Sarrazin; Jean Champagne; Isabelle Nault; François Philippon; Franck Molin; Louis Blier; Gilles O'Hara
Journal:  J Interv Card Electrophysiol       Date:  2011-04-19       Impact factor: 1.900

3.  First experience with a transseptal puncture using a novel transseptal crossing device with integrated dilator and needle.

Authors:  Sergio Rizzi; Luigi Pannone; Gian Battista Chierchia; Carlo De Asmundis; Cinzia Monaco; Antonio Bisignani; Vincenzo Miraglia; Anais Gauthey; Gezim Bala; Maysam Al Housari; Felicia Lipartiti; Joerelle Mojica; Alvise Del Monte; Sahar Mouram; Juan Sieira; Erwin Ströker; Alexandre Almorad; Saverio Iacopino
Journal:  J Interv Card Electrophysiol       Date:  2022-08-09       Impact factor: 1.759

4.  Comparing the safety and effectiveness of dedicated radiofrequency transseptal wires to electrified metal guidewires.

Authors:  Jeremiah Wasserlauf; Bradley P Knight
Journal:  J Cardiovasc Electrophysiol       Date:  2022-01-11       Impact factor: 2.942

5.  Radiofrequency ablation for paroxysmal atrial fibrillation in a patient with dextrocardia and interruption of the inferior vena cava: a case report.

Authors:  Xiaofeng Hu; Shaohui Wu; Mu Qin; Weifeng Jiang; Xu Liu
Journal:  Eur Heart J Case Rep       Date:  2021-05-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.